Arkolith/Insider Trading/ZOM/Form 4

Klass Russell Kevin

Vice President of SalesZomedica Corp. (ZOM) · full profile →Form 4 · filed Nov 12, 2024
Net Buying
Open-Market Buys
$60K
Open-Market Sells
$0
Net Open-Market Flow
$60K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 11, 2024Buy(P)210K$0.12$25K1.2M
Nov 11, 2024Buy(P)290K$0.12$35K1.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-24-014057) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML